Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2018 to Q4 2025

Type / Class
Equity / Common stock, par value $0.01 per share
Symbol
MBOT on Nasdaq
Shares outstanding
73,197,378
Price per share
$1.97
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
11,364,893
Total reported value
$22,729,536
% of total 13F portfolios
0%
Share change
+2,237,624
Value change
+$3,195,261
Number of holders
69
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
INTRACOASTAL CAPITAL, LLC 8.2% $12,004,370 +$12,004,370 6,002,185 Mitchell P. Kopin 15 Jan 2026
VANGUARD GROUP INC 4.4% -20% $7,147,861 +$893,415 2,343,561 +14% The Vanguard Group 30 Sep 2025
CVI Investments, Inc. 4.9% -20% $4,780,994 +$1,487,280 1,824,807 +45% CVI Investments, Inc. 31 Mar 2025

As of 31 Dec 2025, 69 institutional investors reported holding 11,364,893 shares of Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT). This represents 16% of the company’s total 73,197,378 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT) together control 15% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 4.5% 3,329,721 +42% 0% $6,659,442
CIBC Private Wealth Group LLC 2% 1,480,000 +1.8% 0.01% $2,960,000
SUSQUEHANNA INTERNATIONAL GROUP, LLP 1.7% 1,245,123 -0.39% 0% $2,490,246
BlackRock, Inc. 1.2% 868,652 +77% 0% $1,737,304
GEODE CAPITAL MANAGEMENT, LLC 1% 761,995 +54% 0% $1,524,381
DNB Asset Management AS 0.93% 677,498 +178% 0% $1,354,996
UBS Group AG 0.61% 445,132 +119% 0% $890,264
STIFEL FINANCIAL CORP 0.36% 265,990 +69% 0% $531,980
683 Capital Management, LLC 0.35% 256,033 0.04% $512,066
STATE STREET CORP 0.28% 207,169 -0.62% 0% $414,338
AlphaCentric Advisors LLC 0.27% 200,000 0% 0.4% $400,000
JANE STREET GROUP, LLC 0.27% 197,408 +1.9% 0% $394,816
OMERS ADMINISTRATION Corp 0.2% 146,000 0% $292,000
Qube Research & Technologies Ltd 0.18% 131,696 0% $263,392
NORTHERN TRUST CORP 0.16% 114,205 +43% 0% $228,410
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.15% 111,000 0% $222,000
SIMPLEX TRADING, LLC 0.1% 71,227 +255% 0% $142,454
MORGAN STANLEY 0.09% 68,972 +779% 0% $137,944
TWO SIGMA INVESTMENTS, LP 0.08% 61,098 -2.1% 0% $122,196
BARCLAYS PLC 0.08% 59,377 +5937600% 0% $118,754
Virtu Financial LLC 0.08% 58,674 0% $117,000
LPL Financial LLC 0.07% 47,932 -4% 0% $95,864
MILLENNIUM MANAGEMENT LLC 0.06% 46,805 -45% 0% $93,610
Lighthouse Investment Partners, LLC 0.06% 41,100 0% $82,200
Hilltop Holdings Inc. 0.05% 35,764 0% 0% $71,528

Institutional Holders of Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 11,364,893 $22,729,536 +$3,195,261 $2.00 69
2025 Q3 9,849,602 $30,051,548 +$16,711,553 $3.05 67
2025 Q2 4,386,909 $11,055,709 +$5,764,677 $2.52 47
2025 Q1 2,156,269 $3,255,605 +$1,699,280 $1.51 41
2024 Q4 1,103,488 $1,235,663 +$63,070 $1.12 34
2024 Q3 1,044,132 $933,420 -$46,041 $0.89 23
2024 Q2 1,085,208 $1,107,053 -$449,318 $1.02 33
2024 Q1 1,447,970 $1,768,115 -$281,766 $1.23 31
2023 Q4 1,519,532 $2,490,748 +$867,449 $1.64 30
2023 Q3 1,000,057 $1,398,056 -$857,178 $1.39 25
2023 Q2 1,236,959 $3,364,899 -$460,248 $2.72 25
2023 Q1 1,415,902 $2,944,553 -$152,124 $2.08 25
2022 Q4 1,488,966 $4,481,066 +$2,064,567 $3.01 21
2022 Q3 803,086 $3,837,000 +$2,761 $4.78 16
2022 Q2 702,489 $3,605,000 -$247,792 $5.13 16
2022 Q1 741,045 $4,646,000 +$150,132 $6.27 18
2021 Q4 812,545 $6,094,000 +$265,795 $7.50 18
2021 Q3 777,709 $5,467,007 +$107,409 $7.03 16
2021 Q2 754,563 $5,992,008 -$382,067 $7.94 21
2021 Q1 794,962 $6,765,734 +$295,356 $8.51 20
2020 Q4 766,370 $5,280,007 -$45,186 $6.89 16
2020 Q3 772,286 $5,931,008 -$23,065 $7.71 16
2020 Q2 682,819 $4,718,007 -$1,382,287 $6.91 13
2020 Q1 701,275 $3,888,006 +$236,511 $5.51 19
2019 Q4 643,351 $6,542,051 +$350,924 $10.16 16
2019 Q3 613,439 $3,251,026 -$112,684 $5.30 18
2019 Q2 635,786 $3,270,026 +$172,218 $5.13 16
2019 Q1 601,769 $4,664,039 +$3,059,819 $7.75 15
2018 Q4 221,530 $380,009 -$32,735 $1.72 13
2018 Q3 122,245 $909,038 +$909,038 $7.55 11